Performance of BNTX BioNTech SE | -13.9% in 12m
Compare BNTX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare BioNTech SE with its related Sector/Index XBI
Performance Duell BNTX vs XBI
TimeFrame | BNTX | XBI |
---|---|---|
1 Day | 0.68% | 0.67% |
1 Week | 6.14% | 5.92% |
1 Month | 3.13% | 0.44% |
3 Months | -2.76% | 0.91% |
6 Months | -6.38% | 29.64% |
12 Months | -13.9% | 6.11% |
YTD | -16.9% | 0.39% |
Rel. Perf. 1m | 0.30 | |
Rel. Perf. 3m | -1.78 | |
Rel. Perf. 6m | -2.89 | |
Rel. Perf. 12m | -2.30 |
Is BioNTech SE a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, BioNTech SE (NASDAQ:BNTX) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 61.70 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNTX as of May 2024 is 87.36. This means that BNTX is currently overvalued and has a potential downside of -6.42% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNTX as of May 2024 is 87.36. This means that BNTX is currently overvalued and has a potential downside of -6.42% (Sold with Premium).
Is BNTX a buy, sell or hold?
- Strong Buy: 5
- Buy: 4
- Hold: 8
- Sell: 1
- Strong Sell: 1
Values above 0%: BNTX is performing better - Values below 0%: BNTX is underperforming
Compare BNTX with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.86% | 3.49% | -25.79% | -40.91% |
US NASDAQ 100 | QQQ | 4.41% | 3.18% | -26.08% | -51.17% |
US Dow Jones Industrial 30 | DIA | 4.93% | 3.18% | -21.35% | -31.50% |
German DAX 40 | DBXD | 5.88% | 3.14% | -26.19% | -27.34% |
UK FTSE 100 | ISFU | 5.33% | -0.47% | -20.33% | -22.66% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.94% | -0.27% | -8.26% | -2.74% |
Hongkong Hang Seng | HSI | 1.46% | -5.70% | -5.42% | 0.20% |
Japan Nikkei 225 | EXX7 | 3.52% | 5.26% | -22.13% | -33.60% |
India NIFTY 50 | INDA | 6.44% | 2.46% | -24.89% | -40.65% |
Brasil Bovespa | EWZ | 4.31% | 1.50% | -10.93% | -33.19% |
BNTX BioNTech SE vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.46% | 4.61% | -27.66% | -54.59% |
Consumer Discretionary | XLY | 6.25% | 2.59% | -18.91% | -37.02% |
Consumer Staples | XLP | 6.02% | 0.99% | -18.29% | -15.15% |
Energy | XLE | 9.35% | 8.00% | -17.18% | -34.22% |
Financial | XLF | 5.38% | 4.33% | -29.38% | -43.21% |
Health Care | XLV | 5.45% | 4.40% | -17.52% | -21.49% |
Industrial | XLI | 5.71% | 4.45% | -29.81% | -40.62% |
Materials | XLB | 6.36% | 6.04% | -22.48% | -29.30% |
Real Estate | XLRE | 5.71% | 6.65% | -15.18% | -16.34% |
Technology | XLK | 4.03% | 3.87% | -25.37% | -50.51% |
Utilities | XLU | 3.65% | -2.39% | -19.80% | -16.95% |
Aerospace & Defense | XAR | 2.94% | 0.39% | -24.76% | -39.99% |
Biotech | XBI | 0.22% | 2.69% | -36.02% | -20.02% |
Homebuilder | XHB | 3.86% | 4.72% | -46.68% | -66.17% |
Retail | XRT | 4.66% | 3.65% | -27.86% | -37.10% |
Does BioNTech SE outperform its market, is BNTX a Sector Leader?
No, over the last 12 months BioNTech SE (BNTX) made -13.91%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months BNTX made -2.76%, while XBI made 0.91%.
No, over the last 12 months BioNTech SE (BNTX) made -13.91%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months BNTX made -2.76%, while XBI made 0.91%.
Period | BNTX | XBI | S&P 500 |
---|---|---|---|
1 Month | 3.13% | 0.44% | -0.36% |
3 Months | -2.76% | 0.91% | 4.90% |
12 Months | -13.91% | 6.11% | 27.00% |